- PhD, University of Kentucky, 2018
- Pauly NJ, Slavova S, Delcher C, Freeman PR, Talbert JC; Features of prescription drug monitoring programs associated with reduced rates of prescription opioid-related poisonings. Drug and Alcohol Dependence. 2018; March 1(184):26-32. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5854200/
- Pauly NJ, Michailidis L, Kindred M, Flomenhoft D, Walsh S, Lofwall M, Talbert J, Barrett T. Predictors of Chronic Opioid Use in Newly Diagnosed Crohn's Disease. Inflammatory bowel diseases. 2017; 23(6): 1004-1010. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5706777/
- Brown JD, Doshi PA, Pauly NJ, Talbert JC. Rates of Neonatal Abstinence Syndrome Amid Efforts to Combat the Opioid Abuse Epidemic. JAMA Pediatrics. 2016 Nov 1;170(11):1110-2. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5444666/
- Pauly NJ, Talbert JC, Brown J. Low-Cost Generic Program Use by Medicare Beneficiaries: Implications for Medication Exposure Misclassification in Administrative Claims Data. Journal of Managed care and Specialty Pharmacy. 2016 Jun;22(6):741-51. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5737016/
About Nathan Pauly
Dr. Nathan Pauly is the Director of Medicaid Research and Evaluation for the West Virginia University School of Public Health and also maintains an adjunct faculty appointment with the Department for Health Policy, Management, and Leadership. He is a health policy and health services researcher. His research primarily focuses on policy responses to the opioid epidemic as well as Medicaid policy. He is currently embedded within the West Virginia Bureau for Medical Services in Charleston, West Virginia, where he is working to strengthen the agency’s capacity to use data to drive decision making and performance improvement. He previously led an evaluation of the state’s Medicaid Diabetes Health Home Program and is currently assisting with an evaluation of the agency’s 1115 substance use disorder waiver among other projects. He received his PhD in Pharmaceutical Sciences from the Institute for Pharmaceutical Outcomes and Policy at the University of Kentucky. In his free time he enjoys kayaking, backpacking, and fishing.